YOGESH GOSWAMI: Open Payments
NPI 1700970043 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 25 payments from 5 companies in 2025. Trend: 2023 $165 · 2024 $646 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $231 |
| Lundbeck LLC | 7 | $156 |
| Vanda Pharmaceuticals Inc. | 6 | $136 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 1 | $46 |
Products named: ABILIFY ASIMTUFII, FANAPT, COBENFY, ABILIFY MAINTENA, AUSTEDO XR, REXULTI, HETLIOZ.
Industry payments across GA — which companies pay providers there.
